» Articles » PMID: 34771607

Single-Cell Proteomic Analysis Dissects the Complexity of Tumor Microenvironment in Muscle Invasive Bladder Cancer

Overview
Journal Cancers (Basel)
Publisher MDPI
Specialty Oncology
Date 2021 Nov 13
PMID 34771607
Citations 9
Authors
Affiliations
Soon will be listed here.
Abstract

Muscle invasive bladder cancer (MIBC) is a malignancy with considerable heterogeneity. The MIBC tumor microenvironment (TME) is highly complex, comprising diverse phenotypes and spatial architectures. The complexity of the MIBC TME must be characterized to provide potential targets for precision therapy. Herein, an integrated combination of mass cytometry and imaging mass cytometry was used to analyze tumor cells, immune cells, and TME spatial characteristics of 44 MIBC patients. We detected tumor and immune cell clusters with abnormal phenotypes. In particular, we identified a previously overlooked cancer stem-like cell cluster (ALDHPD-L1ER-β) that was strongly associated with poor prognosis. We elucidated the different spatial architectures of immune cells (excluded, infiltrated, and deserted) and tumor-associated collagens (curved, stretched, directionally distributed, and chaotic) in the MIBC TME. The present study is the first to provide in-depth insight into the complexity of the MIBC TME at the single-cell level. Our results will improve the general understanding of the heterogeneous characteristics of MIBC, potentially facilitating patient stratification and personalized therapy.

Citing Articles

Spatially-resolved analyses of muscle invasive bladder cancer microenvironment unveil a distinct fibroblast cluster associated with prognosis.

Feng C, Wang Y, Song W, Liu T, Mo H, Liu H Front Immunol. 2025; 15:1522582.

PMID: 39759522 PMC: 11695344. DOI: 10.3389/fimmu.2024.1522582.


Deciphering the molecular heterogeneity of intermediate- and (very-)high-risk non-muscle-invasive bladder cancer using multi-layered studies.

Akand M, Jatsenko T, Muilwijk T, Gevaert T, Joniau S, Van der Aa F Front Oncol. 2024; 14:1424293.

PMID: 39497708 PMC: 11532112. DOI: 10.3389/fonc.2024.1424293.


Multi-omics analysis unveils the predictive value of IGF2BP3/SPHK1 signaling in cancer stem cells for prognosis and immunotherapeutic response in muscle-invasive bladder cancer.

Wang Y, Song W, Feng C, Wu S, Qin Z, Liu T J Transl Med. 2024; 22(1):900.

PMID: 39367493 PMC: 11452965. DOI: 10.1186/s12967-024-05685-8.


Single-cell high-dimensional imaging mass cytometry: one step beyond in oncology.

Glasson Y, Chepeaux L, Dume A, Lafont V, Faget J, Bonnefoy N Semin Immunopathol. 2023; 45(1):17-28.

PMID: 36598557 PMC: 9812013. DOI: 10.1007/s00281-022-00978-w.


Single-cell sequencing technologies in bladder cancer research: Applications and challenges.

Lyu T, Lin Y, Wu K, Cao Z, Zhang Q, Zheng J Front Genet. 2022; 13:1027909.

PMID: 36338973 PMC: 9627177. DOI: 10.3389/fgene.2022.1027909.


References
1.
Chen Z, Zhou L, Liu L, Hou Y, Xiong M, Yang Y . Single-cell RNA sequencing highlights the role of inflammatory cancer-associated fibroblasts in bladder urothelial carcinoma. Nat Commun. 2020; 11(1):5077. PMC: 7545162. DOI: 10.1038/s41467-020-18916-5. View

2.
Lee H, Chung W, Lee H, Jeong D, Jo A, Lim J . Single-cell RNA sequencing reveals the tumor microenvironment and facilitates strategic choices to circumvent treatment failure in a chemorefractory bladder cancer patient. Genome Med. 2020; 12(1):47. PMC: 7251908. DOI: 10.1186/s13073-020-00741-6. View

3.
Sakaguchi S, Mikami N, Wing J, Tanaka A, Ichiyama K, Ohkura N . Regulatory T Cells and Human Disease. Annu Rev Immunol. 2020; 38:541-566. DOI: 10.1146/annurev-immunol-042718-041717. View

4.
Long X, Xiong W, Zeng X, Qi L, Cai Y, Mo M . Cancer-associated fibroblasts promote cisplatin resistance in bladder cancer cells by increasing IGF-1/ERβ/Bcl-2 signalling. Cell Death Dis. 2019; 10(5):375. PMC: 6510780. DOI: 10.1038/s41419-019-1581-6. View

5.
Zhou Q, Wang Z, Zeng H, Zhang H, Liu Z, Huang Q . Identification and validation of poor prognosis immunoevasive subtype of muscle-invasive bladder cancer with tumor-infiltrating podoplanin cell abundance. Oncoimmunology. 2021; 9(1):1747333. PMC: 7759386. DOI: 10.1080/2162402X.2020.1747333. View